Key message Functional characterization and ectopic expression studies of chalcone synthase mutants implicate the role of phenylalanine in tailoring the substrate specificity of type III polyketide synthase. Abstract Chalcone synthase (CHS) is a plant-specific type III polyketide synthase that catalyzes the synthesis of flavonoids. Native CHS enzyme does not possess any functional activity on N-methylanthraniloyl-CoA, which is the substrate for acridione/quinolone alkaloid biosynthesis. Here, we report the functional transformation of chalcone synthase protein from Emblica officinalis (EoCHS) to quinolone and acridone synthase (ACS) with single amino acid substitutions. A cDNA of 1173 bp encoding chalcone synthase was isolated from E. officinalis and mutants (F215S and F265V) were generated by site-directed mutagenesis. Molecular modeling studies of EoCHS did not show any active binding with N-methylanthraniloylCoA, but the mutants of EoCHS showed strong affinity to the same. As revealed by the modeling studies, functional analysis of CHS mutants showed that they could utilize pcoumaroyl-CoA as well as N-methylanthraniloyl-CoA as substrates and yield active products such as naringenin, 4-hydroxy 1-methyl 2(H) quinolone and 1,3-dihydroxy-nmethyl acridone. Exchange of a single amino acid in EoCHS (F215S and F265V) resulted in functionally active mutants that preferred N-methylanthraniloyl-CoA over p-coumaroyl-CoA. This can be attributed to the increase in the relative volume of active sites in mutants by mutation. Moreover, metabolomic and MS analyses of tobacco leaves transiently expressing mutant genes showed high levels of naringenin, acridones and quinolone derivatives compared to wild-type CHS. This is the first report demonstrating the functional activity of EoCHS mutants with N-methylanthraniloyl-CoA and these results indicate the role of phenylalanine in altering the substrate specificity and in the evolution of type III PKSs.
Introduction
Polyketides are pharmacologically significant, structurally diverse group of secondary metabolites synthesized by a group of enzymes known as polyketide synthases (PKSs). PKSs are classified into three types (types I-III) according to their difference in structure, sequences and catalytic mechanisms (Isvett et al. 2010) . Type I PKSs are common in fungal and bacterial systems that possess multi-domain polyproteins (Austin and Noel 2003) . Type II PKSs are iteratively acting complexes of discrete proteins, with one or more precise functions in the pathway (Hertweck et al. 2007) and are found only in soil-borne and marine Gram-positive actinomycetes (Isvett et al. 2010) . In contrast to types I and II PKSs, type III PKSs (also known as chalcone and stilbene synthases) are widely found in plants and play an important role in the synthesis of secondary metabolites.
Type III PKSs are homodimeric enzymes comprising 40-45 kDa monomeric subunits with a catalytic triad of Cys164, His303 and Asn336 in the active site (Austin and Noel 2003) . Chalcone synthase (CHS) is the most common type III PKS found in higher plants which initiates flavonoid biosynthesis by catalyzing the sequential condensation of 4-coumaroyl-CoA with three acetate moieties of malonyl-CoA to yield naringenin chalcone (Austin and Noel 2003) . Naringenin chalcone on further isomerization and substitution leads to the synthesis of flavones, isoflavonoids and anthocyanins (Hahlbrock and Scheel 1989) . Many PKSs have diverged through gene duplication and differ from CHS based on starter specificity, number of cyclization and type of condensation reactions. The functional diversity, broad substrate specificity and catalytic versatility of type III PKSs can be achieved by minor mutations in the active sites (Mori et al. 2013) .
ACS and QNS enzymes (from Ruta graveolens, Aegle marmelos and Citrus microcarpa) catalyze the synthesis of acridones and quinolones with the condensation of Nmethylanthraniloyl-CoA with malonyl-CoA (Mori et al. 2013) . These alkaloids are reported to have diverse applications as anti-malarial drugs, antagonists of 5-hydroxytryptamine receptors but are mainly confined to Rutaceaen plants (Resmi et al. 2013 ). Due to these important biomedical properties, the biosynthesis of quinolones and acridones are of much interest. Generally, CHS does not accept bulky N-methylanthraniloyl-CoA, but structural manipulations by site-directed mutagenesis will help the protein to accept large substrates. Earlier reports suggest that triple mutant of Medicago sativa CHS (T197L/ G256L/S338I) showed 2-pyrone synthase (PS) activity (Jez et al. 2000) and ACS showed CHS activity with S132T/ A133S/V265F mutations (Lukacin et al. 2001) . A CHS triple mutant (L263M/F265Y/S338G) from Hypericum androsaemum showed higher affinity to benzoyl-CoA than the normal substrate p-coumaroyl-CoA (Liu et al. 2003) . However, so far no attempt has been made to transform CHS into QNS/ACS with functional activity by mutation of gatekeepers F215 and F265 at the active sites.
Of the two phenylalanines located at the active site entrance, F215 is conserved in all type III PKSs except for benzalacetone synthase (BAS) and F265 is replaced by valine in both ACS and QNS (Jez et al. 2002) . The aim of the present study was to diversify CHS activity by introducing substitutions of phenylalanine residues at the juncture of CoA binding tunnel of CHS from Emblica officinalis Gaertn. E. officinalis Gaertn (Phyllanthus emblica Linn.) commonly known as 'Indian gooseberry' belonging to the family Euphorbiaceae is one of the significant medicinal plants found in South Asian subcontinent (Khan 2009) . Here, we demonstrate the role of F215 and F265 in EoCHS by site-specific mutations which further resulted in a multi-functional EoCHS with improved substrate specificity (Fig. 1) . The initial step toward engineering the biosynthetic activity of EoCHS gene was done by in vitro and in planta transient expression studies. The mutant proteins showed enhanced synthesis of quinolone and acridone precursors in comparison to wild-type EoCHS. Further stable expression of EoCHS mutants in plant models will expand its application in the synthesis of nutraceuticals and also in the improvement of plant traits.
Materials and methods

Full-length amplification and cloning of EoCHS
Total RNA was isolated from the leaves of E. officinalis by cetyltrimethylammonium bromide (CTAB)-lithium chloride method (Fu et al. 2004) . cDNA was synthesized and reverse transcribed using the M-MLV reverse transcriptase (Promega, USA) kit. Nested PCR was carried out with degenerate primers. Sequencing was carried out in an ABI-310 PRISM automated sequencer using Big Dye terminator sequencing kit (Applied Biosystems, USA). For the amplification of 5 0 and 3 0 cDNA ends of EoCHS, we used total RNA (10 lg), gene-specific primers and First Choice RNA ligase (RLM)-mediated RACE Kit (Ambion, USA) under the following conditions: 94°C for 3 min, 35 cycles of 94°C for 30 s, 60°C for 30 s, 72°C for 30 s and a final extension of 72°C for 7 min. The PCR product was cloned in pGEM Ò -T Easy Vector (Promega, USA) as per the manufacturer's protocol and propagated in E. coli JM109. Full-length EoCHS was deduced by aligning the 5 0 RACE and 3 0 RACE sequences with the core fragment of EoCHS. Gene-specific primers (Table 1) were used for the amplification of full-length EoCHS. The full-length EoCHS was further used for in silico and transient expression studies.
Southern blotting and bioinformatic analysis
Genomic DNA (25 lg) isolated from the leaves of E. officinalis by the CTAB method was digested with EcoRI and BamH1 (37°C, overnight). The digested product was then subjected to vacuum blotting using VacuGene XL Vacuum blotting system (Amersham Biosciences) and hybridized with [a- 32 P] labeled EoCHS dCTP probe (Prime-a-Gene-Labeling system, Promega).
NCBI BLAST (http://blast.ncbi.nlm.nih.gov/) homology search was used for the identification and confirmation of CHS in E. officinalis. The deduced amino acid sequences Rep (2016 Rep ( ) 35:2077 Rep ( -2090 Rep ( 2079 were aligned with ClustalW2 (Thompson et al. 1994 
Heterologous expression and purification
EoCHS and mutants were cloned into the EcoRI site of the pET32b vector and transformed into competent E. coli BL21 (DE3) cells. For the purification of protein, the transformed BL21 (DE3) cells were grown to A 600 = 0.5 and induced with 1 mM isopropyl-1-thio-galactopyranoside (IPTG) at 25°C for 6 h. The bacterial pellet was then resuspended in buffer A (50 mM NaPO 4 , pH 8.0, 300 mM NaCl, 0.7 mg/mL lysozyme, 10 mM imidazole) and sonicated in ice at 50 % duty cycle at intermediate power. The lysate was analyzed by SDS-PAGE and subjected to nickel nitrilo triacetic acid (NTA)-agarose column chromatography (Invitrogen). After washing with buffer B (50 mM NaPO 4 , pH 7.9, 300 mM NaCl, and 20 mM imidazole), the recombinant proteins were eluted with buffer C (50 mM NaPO 4 , pH 7.5, 150 mM imidazole, and 10 % glycerol), analyzed by SDS-PAGE and the concentration was determined by Bradford assay using BSA as standard.
In vitro enzymatic assay and product analysis
For the in vitro assay of EoCHS and mutants, the standard reaction conditions were set up with 200 lM starter molecule (n-butyryl-CoA, isovaleryl-CoA, n-hexanoylCoA, benzoyl-CoA, cinnamoyl-CoA, p-coumaroyl-CoA, feruloyl-CoA and N-methylanthraniloyl-CoA) and 100 lM malonyl-CoA [inclusive of 9.12 lM [2-14 C] malonyl-CoA (58.40 mCi/mmol)]. Reactions were carried out with 45 lg of protein at 30°C for 2 h and quenched with 5 % acetic acid. The products were extracted two times with 300 lL of ethyl acetate and dried under vacuum. Radio-labeled products were resolved on silica gel 60 F254 TLC plates (Merck) in ethyl acetate/hexanes/acetic acid (63:27:5, v/v/ v). The identity of polyketide products was confirmed by reverse-phase HPLC and LC-MS (Q-TOF) by comparing with the retention time and mass spectra of available standards in the database.
Transient expression in tobacco and metabolite profiling
The binary vector pMDC85 was used for the preparation of expression constructs of EoCHS and its mutants (F215S, F265V). The full-length cDNA of wild-type and mutant CHS gene was amplified using gene-specific primers and cloned into pCR Ò 8/GW/TOPO entry vector (Invitrogen, USA), allowing the addition of attL1 and attL2 sites on the left and right of the insert. Entry clones of wild type and mutants were sequenced before subsequent cloning. The gene constructs were cloned in the binary Gateway destination vector pMDC85 under the control of dual 35S Cauliflower mosaic virus (CaMV) promoter. The C terminus of the CHS protein was fused to the N terminus of GFP in the vector. The resulting binary vector constructs, pMDC85-EoCHS-GFP, pMDC8-F215S-GFP and pMDC85-F265V-GFP, were mobilized into Agrobacterium tumefaciens GV3101 by the freeze-thaw method (Vivek et al. 2013) . Kanamycin (50 mg/L) was used as the selection marker. Empty pMDC85 vector was used as vector control in all experiments. Transient expression was done using a needleless syringe to infiltrate the 'intracellular leaves spaces' of 5-week-old Nicotiana tabacum var. SR1 with overnight cultures of A. tumefaciens grown in nutrient broth at 28°C.
The Agro clones harboring wild-type and mutant constructs were further used for infiltrating the tobacco leaves. After 3 days of infiltration, leaves were harvested for metabolome extraction (Allwood et al. 2010) . About 40 ± 1 mg of leaf extracts were freeze dried and the whole fractions were analyzed by Orbitrap Fusion TM Tribrid TM mass spectrometer as detailed in Cameron et al. (2016) . All experiments were conducted in triplicate along with quality control. Metabolites were detected from 100 to 1000 m/z in full scan positive ionization mode under a varying range of spectrum. Identification of compounds was done by comparing the predicted molecular mass detected in samples with the MS data of polyketides reported. Metabolomic data analysis was done using the numerical calculations after profiling. The respective metabolite intensities were analyzed by principal component analysis (PCA) using MetaboAnalyst 3.0 software (http://www.Metaboanalyst. ca).
Results
Full-length isolation, genomic organization and in silico analyses of EoCHS A partial cDNA of 600 bp encoding CHS was cloned from young leaves of E. officinalis by RT-PCR and confirmed by sequencing. RACE-PCR resulting in 5 0 755 bp and 3 0 70 bp fragments, respectively. Full-length coding sequence (1173 bp) of EoCHS was amplified by PCR ( Fig. 2a ) using gene-specific primers. The full-length EoCHS sequence obtained has been submitted to GenBank (accession no.: KJ155834). The primary sequence of EoCHS exhibits 81 % similarity with known CHSs and the deduced amino acid sequence showed about 90 % identity with the CHS of Hypericum sampsonii and Camellia chekiangoleosa. Southern blot of EoCHS resulted in bands differing in size from 1 to 10 kb (Fig. 2b) . Existence of multiple forms of PKS was reported from Arabidopsis thaliana (seven) and Pisum sativum (eight) (Abe et al. 2005) . Our study indicates the occurrence of five CHS isoforms in Emblica genome, which clearly suggests EoCHS polymorphism which may be due to the re-arrangement of CHS-like genes during the process of evolution (Matousek et al. 2002) . This would contribute to the functional diversity of flavonoids, which are constitutively expressed, while others are transcriptionally induced by other factors (Sun et al. 2011) . EoCHS gene encoding 390 amino acid residues with a molecular mass of 42.56 kDa and an isoelectric point (pI) of 6.11 were found to be stable and localized in the cytoplasmic matrix. Multiple sequence alignment of EoCHS protein with other plant-specific PKSs revealed that almost all the conserved amino acid residues [catalytic sites: C164-H303-N336; substrate binding pocket: S133-E192-T194-T197-S338; and cyclization pocket: T132-M137-F215-I254-G256-F265-P375 (numbering as per Medicago sativa CHS)] were maintained in EoCHS (Ferrer et al. 1999) (Fig. 3a) . EoCHS shared 81% amino acid identity and possess conserved putative domains with other plant CHSs which suggested that EoCHS might catalyze the synthesis of naringenin chalcone. However, it showed only 58-74 % similarity to acridone and quinolone forming type III PKSs. In the case of MP (Dopazo 1994 )-based phylogram, EoCHS clustered with the CHSs from Hypericum sp. (Fig. 3b) . All the chalcone-forming type III PKSs including EoCHS were grouped together (group 1 in Fig. 3b ) with the exception of Z. officinale CHS (Radhakrishnan et al. 2009), which was clustered along with non-CHS type of PKSs. Phylogenetic studies showed its closer relationship to Hypericaceae and Theaceae which were consistent with the earlier studies that there exists a high level of sequence homology between CHSs of higher plants.
Substitution of phenylalanine alters the cavity volume in EoCHS mutants
Mutants are ideal for studying the role of active residues in framing the structure of CHS. Recently, various crystallographic and site-directed mutation studies have revealed the functional and structural diversity of PKSs (Ferrer et al. 1999) . Mutants of EoCHS (F215S and F265V) were generated and the mutations confirmed by sequencing (Fig. 4) . The mutants were further studied by molecular modeling and docking. Due to the lack of X-ray crystal structure, a homology model of EoCHS was constructed to characterize the structural properties (Fig. 5a ) based on the crystal structure of alfalfa CHS (PDB ID: 1BI5A, resolution 1.56 Å ). The stereo-chemical quality of the model was confirmed using Ramachandran plot (Fig. 5b) . Ramachandran plot showed that 97.4 % of the residues group in the energetically favoured region, 2.3 % residues were in the allowed region and 0.3 % on the outer region. The structural validation confirmed that the majority of the residues ([90 %) were grouped in the energetically favoured regions. Moreover, the ERRAT score of 90.765 for EoCHS confirmed that the predicted model was of good quality. In our study, EoCHS 3D homology model showed 84 % similarity with the typical alfalfa CHS. The modeled enzyme possessed a thiolase fold with a conserved ababa core structural architecture with the catalytic triad (C-H-N) retained in the same position. In the same way, homology models were generated for the mutants F215S and F265V. Structural comparison between wild-type and mutant CHSs provided evidence for the difference in substrate specificity. Docking studies with p-coumaroyl-CoA showed effective binding in the active site of wild-type EoCHS (E-total -390.38 kJ), while the bulkier substrate N-methylanthraniloyl-CoA did not show any interaction. Previous studies also supported this observation where CHS was unable to catalyze N-methylanthraniloyl-CoA in vitro (Jez et al. 2002) . Interestingly, the homology model of EoCHS mutants has a similar structural fold to that of the wild type, but showed an increase in cavity volume. The mutation aimed at the replacement of phenylalanine at Fig. 3 (Fig. 6a) , which were higher than that of the wild type (1167Å ). This suggested that the substitution of phenylalanine with serine at 215 and valine at 265 resulted in the expansion of cavity of the active site which was large enough to accommodate bulkier substrates. Further, the two mutants F215S and F265V were subjected to docking studies with p-coumaroyl-CoA and N-methylanthraniloylCoA. Both the mutants were able to accept p-coumaroylCoA and N-methylanthraniloyl-CoA. In the wild type, F-215 prevents the binding of N-methylanthraniloyl-CoA moiety by shrinking the cavity space due to its size. The serine group at 215 (Fig. 6b) and valine at 265 supported the mutants in productive binding of N-methylanthraniloylCoA by forming an enzyme-substrate hydrogen bond (Fig. 6c) . Site-directed mutation at F215 and F265 of EoCHS by serine and valine shed insights into the role of phenylalanine in modulating the substrate binding pocket and the affinity toward bulkier CoAs.
Ectopic expression and functional characterization of EoCHS and mutants
EoCHS and mutant (F215S and F265V) constructs were overexpressed in E. coli BL21 (DE3). The recombinant protein was expressed as a thioredoxin (Trx) fusion protein along with a histidine tag. We found that the induction with 1 mM IPTG followed by 6 h incubation at 25°C gives a maximum yield for recombinant protein. EoCHS and mutant proteins were prepared in large scale and purified by Ni-NTA affinity chromatography. The purified proteins gave a single band of 62 kDa (Fig. 7a) on SDS-PAGE, with a yield of 1.4 mg/L for EoCHS and 1 mg/L for mutants.
According to in silico studies, wild-type EoCHS showed putative chalcone synthase activity, whereas the mutants were able to accommodate N-methylanthraniloyl-CoA in their substrate binding pocket. To confirm this, the in vitro assay was performed using various aliphatic and aromatic substrates. As predicted in protein-substrate docking studies, the recombinant wild-type EoCHS formed naringenin, as a major product when incubated with p-coumaroyl-CoA and [2-14C] malonyl-CoA. Several significant bands appeared on the TLC plate indicating that the EoCHS protein is able to accept a wide range of aliphatic and aromatic substrates (Fig. 7b) but no products were detected in N-methylanthraniloyl-CoA-primed reaction. This supported the earlier studies in CHS protein, where it was unable to catalyze bulkier N-methylanthraniloyl-CoA. In support of our homology modeling studies, our in vitro assays with mutants resulted in products with p-coumaroylCoA (Fig. 7c) and N-methylanthraniloyl-CoA-primed reactions (Fig. 7d) . We decided to confirm the identity of products formed using reverse-phase HPLC and LC-MS (Q-TOF) with available standards in the database. The major product from p-coumaroyl-CoA-primed reaction with EoCHS and mutant proteins showed similar HPLC profile and retention time as that of naringenin (Sigma) (R t = 26.732, reference compound). The absolute amounts of the individual enzymatic products obtained were estimated based on their absolute peak areas on the HPLC chromatograms ( Fig. 8a) with the standard, naringenin. Thus, our studies suggest that EoCHS belong to CHS family of PKSs and both the mutants were also able to utilize p-coumaroyl-CoA to yield naringenin which is the precursor for flavonoid biosynthesis.
As anticipated, the major products from F215S mutant on MS analysis showed similar mass spectra to 4-hydroxy 1-methyl 2(H) quinolone (Sigma) and 1,3-dihydroxy-nmethyl acridone (Sigma). On MS analysis, the product of F215S primed reaction with N-methylanthraniloyl-CoA yielded dominant ion peak at m/z 176.0726 [M?H] ? and minor product at m/z 242.0839 [M?H] ? (Fig. 8b) . The spectroscopic and MS data of both the products were characteristic of 4-hydroxy 1-methyl 2(H) quinolone and 1,3-dihydroxy-n-methyl acridone derivatives as reported in literature (Resmi et al. 2013 ). The results suggest that F215 mutant protein was able to condense N-methyl anthraniloylCoA to yield diketide 4-hydroxy 1-methyl 2(H) quinolone and 1,3-dihydroxy-n-methyl acridone. At the same time, F265V mutant primed reaction with N-methylanthraniloylCoA resulted in the formation of acridone without diketide formation. MS analysis of the product revealed a fragment at m/z 196.07 [M?H] ? (Fig. 8c) . It did not show the formation of quinolone derivatives in vitro. In the assay catalyzed by F215S protein, exclusive formation of lactones was detected on MS analysis, which indicates that the starter CoA in the reaction will not be a physiologically relevant substrate for the enzyme in vitro (Resmi et al. 2013) . This supports our studies that for CHS the relevant substrate is p-coumaroylCoA, whereas the mutants were able to perform sequential condensation with the non-physiological substrate Nmethylanthraniloyl-CoA. To date, F215S mutant of other CHS has been reported to generate only N-methylanthraniloyl triacetic acid lactone (Jez et al. 2002) . Interestingly, our study indicates that the generation of EoCHS mutants with modification at the phenylalanine site might have remarkably improved its catalytic properties, which resulted in enhanced enzyme activity. This is the first report where CHS mutants with single amino acid substitution produced quinolone and acridone derivatives, but the chemistry behind the physiological relevance of bulkier substrates still remains to be determined.
Detection of N-methylanthraniloyl-CoA in tobacco by high-resolution metabolomics
Metabolomics have been suggested to be the ultimate level of post-genomic analysis as they reflect both transcriptional and post-transcriptional regulation. Till date, whole metabolomic data of tobacco is not available. Therefore, initially we carried out a metabolomics analysis for determining the responses in tobacco by mass spectrometry-based identification and quantification of metabolites.
According to previous studies, there existed the question regarding the presence of N-methylanthraniloyl-CoA in tobacco. For example, in planta expression studies with quinolone synthase (QNS) in tobacco by Resmi et al. (2015) suggested that N-methylanthraniloyl-CoA might be absent. However, in the plant system we cannot rule out the possibility of the existence of N-methylanthraniloyl-CoA, as it could be due to the absence of specific type III PKS enzyme. There are chances that these substrates are available in trace levels and this can only be detected by high resolution MS-based profiling of total metabolites. In our metabolomics data, we detected the presence of fragment with m/z value 899.16 [M-H] -which corresponded to Nmethylanthraniloyl-CoA, whose exact mass is 900.16 (KEGG database). Compared to the control and the wild type, the mutant-infiltrated leaves showed high abundance of N-methylanthraniloyl-CoA, which confirms the existence of N-methylanthraniloyl-CoA in tobacco (Supplementary Fig. S1 ). This clearly suggests that overexpression ? m/ z 196.07. The structure of the molecule is drawn beside its MS/MS spectra of mutants recruits N-methylanthraniloyl-CoA resulting in the production of quinolone and acridone derivatives. Thus, our study confirms the presence of N-methylanthraniloyl-CoA in tobacco and, further, the expression of EoCHS mutants were validated.
In planta expression analysis of mutants in tobacco leaves
Metabolite profiling has established its role in characterizing transgenic plants based on the metabolomics data. To study in planta variation in the substrate specificity and product formation of wild-type and mutant CHS, the total ion profiles were screened. The metabolic profiles obtained for tobacco leaves transiently expressing wild-type and mutant EoCHS showed variation. The expression level of metabolites was checked by non-targeted metabolomics approach. There was an explicit difference observed in PCA in the grouping pattern of wild-type and mutant (F215S and F265V) infiltrated leaf samples. This accounted for over 79.6 % variation in the metabolite profiles (Fig. 9a) . In the metabolite analysis by MetaboAnalyst, PCA showed a clear differential clustering pattern between mutants and wild-type CHS metabolite profiles. F215S and F265V were clustered separately which confirms that there is a clear variation in the expression of metabolites in the mutants from the wild-type CHS. Based on their distribution with respect to the PC2 axis, the samples are qualitatively grouped into five clusters (control, normal, wild, F215S and F265V) (Fig. 9a) . The heat map analysis showed high abundance of flavonoids (catechin, flavanone, isoflavone, kaempferol and naringenin) in the mutants than in the wild type (Fig. 9b) . In addition to the changes in major flavonoids, significant expression of quinolone and acridone derivatives was found in mutants. To study the expression of specific metabolites due to transgenic expression of wild-type and mutant EoCHS, metabolite identification was carried out using the reported PKS Plant Cell Rep (2016 Rep ( ) 35:2077 Rep ( -2090 Rep ( 2087 products. Interestingly, we found high levels of 4-hydroxy 1-methyl 2(H) quinolone and 1,3-dihydroxy-n-methyl acridone in F215S and F265V transgenic leaves. In the EoCHS-infiltrated leaf extracts, these metabolites were present in very low quantities. This suggests that EoCHS cannot catalyze the formation of 4-hydroxy 1-methyl 2(H) quinolone and 1,3-dihydroxy-n-methyl acridone, which are the precursors of quinolone/acridone alkaloids. Further, on analysis, high abundance of 4-hydroxy 1-methyl 2(H) quinolone and 1,3-dihydroxy-n-methyl acridone was found in the leaves with the mutant CHSs than in wild-type leaves (Fig. 9b) . MS profile of F215S (Fig. 9c) and F265V (Fig. 9d) , respectively. Unlike the wild type, the mutants showed accumulation of 4-hydroxy 1-methyl 2(H) quinolone and 1,3-dihydroxy-n-methyl acridone, which implicates the role of phenylalanine in modulating the substrate affinity. In leaves infiltrated with F265V mutant, the levels of 4-hydroxy 1-methyl 2(H) quinolone and 1,3-dihydroxy-n-methyl acridone was low compared to those infiltrated with F215S mutants. Comparison of F215S and F265V mutation indicates that the substitution of serine for Phe-215 allows for the productive binding of Nmethylanthraniloyl-CoA. Moreover, the expression level of major flavonoids (naringenin and kaempferol) was high in leaves infiltrated with the mutants than with the wild-type CHS. This clearly supports our docking and in vitro studies where the mutants showed productive affinity with Nmethylanthraniloyl-CoA, the starter substrate for quinolone/acridone biosynthesis. Overall, our study suggests that both the mutants were able to accept N-methylanthraniloylCoA to yield 4-hydroxy1-methyl 2(H) quinolone and 1,3-dihydroxy-n-methyl acridone which are the precursors of quinolone/acridone alkaloids. The expression of alkaloid derivatives in planta can be linked to the activity of the mutant CHS enzyme to catalyze N-methylanthraniloylCoA-primed reaction, thus leading to the synthesis of a wide array of secondary metabolites such as hydorxy quinolones, acridones and other flavonoids.
Discussion
CHS and other plant-specific type III PKS catalyze the formation of polyketides and other intermediates with specific cyclization and condensation of starter CoAs. These enzymes share 70 % amino acid identity among the PKS family, which suggests the functional divergence of these enzymes. Currently, structure-based engineering of PKS has significantly expanded for the synthesis of various unnatural polyketides. The two gatekeepers (F215 and F265) at the active site of CHS have been attractive targets for structural engineering of PKS (Jez et al. 2002) .
Quinolones and acridones are restricted to the Rutacean family of PKS enzymes and these compounds have significant pharmacological activities (Resmi et al. 2013) . Previously, efforts have been made to transform native CHS to quinolone/acridone synthesizing enzyme for the in vitro production of alkaloids. In this study, we have isolated CHS from E. officinalis (EoCHS), which was subsequently subjected to site-directed mutagenesis. Thus, two CHS mutants (F215S and F265V) were generated, aiming to alter substrate specificity of EoCHS protein.
Replacing the phenylalanine residues lining the entrance of the active site by serine and valine has resulted in a remarkable increase in the cavity volume. The cavity volume for F215S (1277.5 Å ) and F265V (1187 Å ) was found to be larger than wild type EoCHS (1167 Å ). We therefore presumed that the mutants could accept bulkier starter units such as N-methylanthraniloyl-CoA. Further, our docking studies showed effective binding of N-methylanthraniloylCoA with mutants. To validate our hypothesis, in vitro and in planta functional characterization of mutants were carried out. Here, we report the functional validation of CHS mutants capable of catalyzing quinolone/acridone biosynthesis.
Mutants were generated with multiple amino acid substitution (2-pyrone synthase to CHS, ACS to CHS, benzophenone synthase to CHS and STS to CHS) (Abe et al. 2003) . Previously, double and triple CHS mutants were generated, but none of them was found to be successful in generating functional products. It was found easier to transform non-CHS to CHS enzyme by few mutational changes (ACS to CHS, Lukacin et al. 2001) . Although, the M. sativa CHS F215S mutant has been shown to accept N-methylanthraniloyl-CoA, it does not catalyze the biosynthesis of acridone or quinolone (Jez et al. 2002) . Here, native form of EoCHS was able to catalyze a range of aliphatic and aromatic substrates with an exception of Nmethylanthraniloyl-CoA. Interestingly, both CHS mutants were able to utilize p-coumaroyl-CoA as well as bulkier N-methylanthraniloyl-CoA as starter substrate and resulted in the formation of naringenin, 4-hydroxy 1-methyl 2(H) quinolone and acridone. Although, our in vitro studies showed functional activity of CHS mutants in catalyzing N-methylanthraniloyl-CoA and p-coumaroyl-CoA, structural knowledge is necessary to understand the steric differences in determining the substrate affinity.
Here, we used a metabolomics-based approach to identify the possible metabolites in tobacco leaves transiently expressing EoCHS wild type and mutants. Preliminary metabolomics data from transgenic leaves expressing F215S and F265V showed the presence of 4-hydroxy 1-methyl 2(H) quinolone and 1,3-dihydroxy-n-methyl acridone, which were less abundant in EoCHS-infiltrated leaves. This indicates that EoCHS is unable to catalyze Nmethylanthraniloyl-CoA-primed reaction. In addition, the levels of other major flavonoids (naringenin and kaempferol) were observed to be high in mutant (F215S and F265V)-infiltrated leaves as compared to the levels in wild type (EoCHS). The MS profile of F215S showed high abundance of 4-hydroxy 1-methyl 2(H) quinolone and 1,3-dihydroxy-n-methyl acridone than F265V. This implicates that single site mutation of phenylalanine has not only changed the substrate specificity of EoCHS from p-coumaroyl-CoA to N-methylanthraniloyl-CoA but has also transformed EoCHS into functional quinolone/acridone synthesizing enzyme. Previously, studies of Jez et al. (2002) and Abe et al. (2003) had shown that single amino acid substitution of phenylalanine at 215 and 265 active sites of CHS produced N-methylanthraniloyl triacetic acid lactone, pyrone and other triketide lactones. Contrary to our expectations, the EoCHS mutants (F215S and F265V) showed altered substrate specificity and preferentially accepted p-coumaroyl-CoA and N-methylanthraniloylCoA. To date, this CHS variant has not been reported to produce active products in tobacco. Interestingly, our study suggests that F215S and F265V mutant of EoCHS might have undergone widening of active site which allowed the formation of quinolone and acridone derivatives by utilizing the substrates available in plant. Further studies are required in plant models such as Arabidopsis to clearly support the physiological preference of EoCHS mutants.
In summary, this is the first report of functional conversion of CHS to QNS/ACS with single amino acid substitution. These results suggest an evolutionary relationship between CHS and QNS/ACS which could further lead to the in vitro synthesis of novel natural polyketides from plants. The metabolomics data strongly support the activity of mutants within the plant system. Our study provides a platform for the engineering of type III PKS that can be utilized for the production of structurally and chemically distinct novel compounds with potential pharmacological significance and also to expand its application in the development of plants with improved traits.
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